Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Unilever Plc | LSE:ULVR | London | Ordinary Share | GB00B10RZP78 | ORD 3 1/9P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 41.00 | 0.87% | 4,733.00 | 10,461,550 | 16:35:16 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 4,736.00 | 4,737.00 | 4,737.00 | 4,702.00 | 4,709.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Perfume,cosmetic,toilet Prep | EUR 59.6B | EUR 6.49B | EUR 2.6082 | 18.16 | 116.7B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 17:54:31 | O | 456,315 | 4,709.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/11/2024 | 15:56 | ALNC |  Unilever eyes higher return on investment; on track for Ice Cream exit |
| 22/11/2024 | 13:00 | UK RNS | Unilever PLC Unilever Investor Event |
| 15/11/2024 | 20:20 | ALNC | Ben & Jerry's lawsuit accuses parent firm Unilever of Gaza censorship |
| 11/11/2024 | 12:30 | UK RNS | Unilever PLC Director/PDMR Shareholding |
| 05/11/2024 | 17:27 | UK RNS | Unilever PLC Completion of 2024 Share Buyback |
| 05/11/2024 | 17:00 | UK RNS | Unilever PLC Transaction in Own Shares |
| 04/11/2024 | 17:21 | UK RNS | Unilever PLC Transaction in Own Shares |
| 01/11/2024 | 17:41 | UK RNS | Unilever PLC Transaction in Own Shares |
| 01/11/2024 | 14:14 | UK RNS | Unilever PLC Total Voting Rights |
| 31/10/2024 | 17:15 | UK RNS | Unilever PLC Transaction in Own Shares |
Unilever (ULVR) Share Charts1 Year Unilever Chart |
|
1 Month Unilever Chart |
Intraday Unilever Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/11/2024 | 14:18 | Unilever - The Dream and Safe Ticket | 3,144 |
| 11/2/2022 | 15:16 | Good Gain Today | - |
| 02/2/2022 | 20:20 | ::: UNILEVER 2021 ::: | 39 |
| 27/1/2022 | 14:05 | Magnum | - |
| 25/1/2022 | 16:18 | Holding Steady | - |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-11-27 17:54:32 | 4,709.00 | 456,315 | 21,487,873.35 | O |
| 2024-11-27 17:54:32 | 4,709.00 | 400,000 | 18,836,000.00 | O |
| 2024-11-27 17:54:32 | 4,709.00 | 400,000 | 18,836,000.00 | O |
| 2024-11-27 17:54:32 | 4,709.00 | 400,000 | 18,836,000.00 | O |
| 2024-11-27 17:54:20 | 4,709.00 | 400,000 | 18,836,000.00 | O |
| Top Posts |
|---|
Posted at 27/11/2024 08:20 by Unilever Daily Update Unilever Plc is listed in the Perfume,cosmetic,toilet Prep sector of the London Stock Exchange with ticker ULVR. The last closing price for Unilever was 4,692p.Unilever currently has 2,487,119,079 shares in issue. The market capitalisation of Unilever is £117,814,830,772. Unilever has a price to earnings ratio (PE ratio) of 18.16. This morning ULVR shares opened at 4,709p |
Posted at 08/11/2024 10:10 by anhar As an income investor and very long term holder I'm well aware that unfortunately quarterly divis remained unchanged at 42.68 eurocents for as long as 14 quarters between Q4 2020 and Q1 2024. In Q2 2024 it was raised 3% to 43.96€¢, which nowhere near makes up for the lengthy 3 1/2 year stasis of the payouts during which inflation did its business.Naturally this history is way better than cuts but imo ULVR is perhaps not quite the divi hero. The sterling values will differ due to fluctuating FX rates but it's the euro values that tell us the company's policy. |
Posted at 06/11/2024 17:05 by alotto The dividend yield is not enough to support further appreciation.unikeveI expect the demerger of the ice cream business will boost significantly the share price by 2025 end. I was out at £47. I missed the dividend payment. I will get back in if we test £44. Unilever moves too slowly even for trading in and out |
Posted at 01/11/2024 18:48 by xtrmntr Unilever (ULVR) delivered a stronger than expected underlying performance in its third quarter as its ice cream arm, which the consumer goods giant hopes to spin off by the end of 2025, benefited from a soft comparative. Underlying sales growth came in at 4.5 per cent in the quarter, ahead of the company-compiled consensus of 4.2 per cent, as ice cream sales rose 9.8 per cent. Stripping out the ice cream performance, which management attributed to distribution gains, promotions and product innovations, sales rose 3.6 per cent.Underlying volume growth of 3.6 per cent also beat consensus. Total revenue of 15.2bn (£12.6bn) was flat, a result impacted by currency headwinds and net disposals. The spin-off of the ice cream unit, which sells brands including Magnum and Ben & Jerry's, is part of chief executive Hein Schumacher's growth strategy. The unit has historically posted slower growth than other parts of the portfolio, while Ben & Jerry's has caused legal headaches for the business. Unilever said it had made progress with setting up a separate ice cream legal entity and operating model.Another part of the plan is a focus on the company's top "power brands", which deliver more than three-quarters of revenue. In the third quarter, these brands outperformed, with underlying sales and volume growth of 5.4 per cent and 4.3 per cent, respectively.Meanwhi |
Posted at 24/10/2024 16:27 by laurence llewelyn binliner #BC10, same here with c150 pence a year income.. :o)Interesting to note RKT went +175 pence then -92 today ULVR went -100 pence then +137 today Just let HS get on with implementing his strategy and see where we go, next change will be the spinning off of the ice cream business and see how that impacts share price performance.. Most holders will be more focused on the 30th budget, how it hurt and what they can do about it (if anything) .. |
Posted at 20/9/2024 17:56 by xtrmntr As befits their role as 'bond proxies', the attractions of consumer staples shares were damaged when interest rates have increased from record lows. At the same time, inflationary pressures have led consumers to trade down to private label options in the hunt for cheaper products.Companies have struggled to strike the right balance between volume and price; Procter & Gamble's (US:PG)'s sales volumes were flat in its latest financial year, while Nestlé's (CH:NESN) preferred real internal growth metric grew by just 0.1 per cent in its first half. But as base rates start to drop, some businesses are also starting to see belated operational progress. Unilever (ULVR) has delivered quarter-on-quarter volume growth over the past three periods, as chief executive Hein Schumacher (in post since July 2023) implements a fresh growth strategy in an attempt to improve earnings and margins after an underwhelming few years.A turnaround story under new management understandably excites the market, and the Marmite and Dove owner's share price has risen by almost a quarter over the past year. Change was badly needed; Schumacher's promise of "no major or transformational acquisitions" came after the attempted £50bn acquisition of GSK's (GSK) consumer arm in 2022 went down like a lead balloon with investors.The new plan has several parts: a focus on top brands (which deliver three-quarters of revenue and are higher-growth than the rest of the portfolio), a spin-off of the underperforming ice-cream arm, and a cost-cutting and productivity package. On the face of it, this looks encouraging. But rejuvenation narratives can sometimes deceive. Analysts at Bernstein have pointed to "the low odds of turnaround in this space", and Unilever's "own history of repeated turnaround hopes for at least the last 28 years". Saying that, the latest trading figures contained encouraging signs. Half-year results to 30 June saw a big operating profit margin beat and raised guidance. The gross margin was boosted by 420 basis points as management tries to return the metric to pre-pandemic levels. However, it remains the case that competitiveness needs to improve, judging by a turnover-weighted market share metric that remains flat.The question for income investors is what the new strategy means for dividends. Unilever's reliable payouts have made it an income stalwart. It has grown dividends per share at a compound annual growth rate of 5 per cent over the last decade nicely ahead of competitors.It's important to note that Unilever reports in euros, with investors holding the London-listed shares receiving dividends in pounds and those holding the Amsterdam-listed shares paid in euros. Dividend payments in pounds have, unsurprisingly, fluctuated because of currency movements. But a fully-fledged cut is essentially unheard of.Payouts are backed up by chunky free cash flow generation and a resilient balance sheet. Unilever delivered 7.1bn (£6bn) of free cash flow last year, allowing the return of 5.9bn to investors in dividends and buybacks. Analysts expect 6.9bn and 7.8bn of free cash flow to be posted in 2024 and 2025, respectively, rising to over 8bn in 2026. Net debt of around 25bn at the end of June, translating to a leverage ratio of 2 times, is manageable and doesn't present a risk to these plans.Combine these factors with the new strategy's hoped-for improved growth and earnings, and the conclusion might be that the payout outlook is rock solid. We expect dividends to grow in the coming years. There is some uncertainty about what Schumacher's new strategy means for future demands on capital expenditure and research and development spend, and the context of the planned hive-off of the ice cream business provides more complexity when thinking about future investor returns. This introduces some new risks into the equation, but the overall picture is promising.Dividend policy: A payout ratio above 60 per cent of underlying earnings. Yield: 3 per centPayment: QuarterlyLast cut: naAlternativeLike Unilever, Diageo (DGE) also has relatively new management. But the drinks giant's share price has moved in the opposite direction over the last year, as chief executive Debra Crew remains under pressure on the back of inventory headwinds in Latin America and weaker demand in the key North America market. In the latest annual results, revenue went backwards for the first time in four years and operating profits fell in four out of five markets. Despite these significant hangovers, analysts expect dividends to continue to grow, backed up by expectations for free cash flow to rise by almost $1bn (£766mn) between 2024 and 2027. |
Posted at 29/8/2024 22:47 by philanderer The TelegraphQuestor: Be optimistic about this consumer giant’s future dividend pay outs Questor says: buy Ticker: ULVR Share price: 4,912p |
Posted at 04/8/2024 12:58 by xtrmntr From Investors Chronicle Consumer staples giants Reckitt Benckiser (RKT) and Unilever (ULVR) are both attempting to divest from underperforming business areas as they focus on their top "power brands" in a bid to build market share, cut costs and fend off investor pressure.Last week, Reckitt announced plans to streamline operations and focus on a "high-growth, high-margin" core brand portfolio which delivered a 61 per cent gross margin in 2023 and a five-year like-for-like net revenue compound annual growth rate of 7 per cent.It aims to sell a portfolio of home care brands, including Air Wick, Mortein, Calgon and Cillit Bang, which contributed 13 per cent of net revenue last year. It is also examining "all strategic options" around its infant formula nutrition business Mead Johnson, which suggests a sale of the struggling unit it acquired for $17bn (£13bn) in 2017. The subsidiary posts almost a fifth of the company's net revenue.The fresh strategy under new chief executive Kris Licht is similar to the transformation plan at Unilever. Boss Hein Schumacher, who like Licht took the reins last year, is spearheading a growth plan which focuses on the company's 30 biggest brands. In the latest half, these contributed three-quarters of revenue and outperformed the rest of the business on underlying sales and volume growth. Unilever is also trying to split off its ice cream business, its smallest unit which delivers 15 per cent of revenue between brands Wall's, Magnum and Ben & Jerry's.Both companies have also taken the axe to employee numbers. Reckitt is aiming to cut its fixed cost base from 22 per cent to 19 per cent of net revenue, while Unilever is slashing 7,500 jobs and has guided for $800mn of cost reductions over three years. Restructuring charges are guided to come in £1bn in the three years to 2027 at Reckitt, and 1.2 per cent of revenue this year at Unilever.Plan potentialReckitt is the higher-margin business, which is the context in which Unilever's goal of achieving "a structurally higher margin" must be seen. For the six months to 30 June, Reckitt recorded an underlying operating margin of 24 per cent and gross margin of 61 per cent, compared to 20 per cent and 46 per cent, respectively, at its competitor.But the big question mark over Reckitt's strategy comes from ongoing legal headaches at Mead Johnson. Reckitt's shares were hit this week after infant formula rival Abbott Laboratories (US:ABT) lost a $500mn court case in Missouri over allegations it refused to warn that its products can cause the necrotising enterocolitis (NEC) bowel disease. Reckitt lost a $60mn case in Illinois on the issue in March, and more cases are incoming. It is increasingly uncertain if there will be interested buyers queuing up for the division.Analysts at Jefferies estimated that Reckitt's share price "is already discounting for $3.5bn of liability risk" for NEC issues in 2025. But with an NEC trial involving Reckitt kicking off in Missouri in September and multidistrict litigation (MDL) action building up, "that risk may be extended".By contrast, the removal of Unilever's ice cream arm is more straightforward, and would take out a low-margin part of the business which has caused internal legal headaches through subsidiary Ben & Jerry's attempts to stop sales in Israel. It could also help boost underlying sales growth to the higher end of management's 3-5 per cent target range, given the unit's relatively weak performance.Unilever reported a 420 basis point rise in gross margin alongside an increase to annual underlying operating margin guidance in its first half, and boosted brand investment ahead of peers, but margin recovery looks more difficult in the near-term.Analysts at Berenberg said that "while execution remains key [including innovation activity], we think that the recovery in US prestige beauty, easing competition in China, better weather in Europe and easing boycotts on western brands in Indonesia" could boost the company's growth next year.The new strategies come as price hike rates slow across consumer staples as inflation subsides. Nestlé (CH:NESN) said this week that price growth of 2 per cent in its half-year results had come "down faster than expected". Unilever's underlying price growth of 1 per cent in its second quarter was similarly lower than expected by analysts.ValuationsU |
Posted at 03/5/2024 07:23 by xtrmntr The strong performance by Reckitt (RKT) and Unilever (ULVR) in the first quarter proved a relief to investors, with their share prices subsequently gaining 6 per cent and 7 per cent, respectively. Only a few months ago, both companies were struggling to sustain volumes and margins against a relentlessly tough macro backdrop.Whether these trading updates indicate an imminent recovery or a temporary reprieve depends on who you ask.In Unilever's case, brokers remain divided over longer-term growth prospects. Berenberg is firmly in the bullish camp, with its analysts stating that the company's recent performance supports a re-rating of the stock. "We are pleased to see the group deliver volume growth that is meaningfully higher than that achieved by industry bellwethers," they said.The investment bank named Procter & Gamble (US:PG) and Nestlé (CH:NESN) as the most relevant comparators. The former managed no volume growth across the three months to the end of March, while the latter saw "real internal growth" its preferred measure fall by 2 per cent. Meanwhile, Unilever reported underlying volume expansion of 2.2 per cent up from 1.8 per cent in the final quarter of FY2023. It also achieved consensus-beating revenue growth in all three of the regions in which it operates.Unilever is still in the implementation phase of its growth action plan, which should give glass-half-full types confidence in further upgrades. Chief executive Hein Schumacher introduced the scheme centred around boosting the company's power brands last autumn. Although broker UBS acknowledged that it appears to be yielding some early benefits, it maintains a sell rating on the company."Our view remains that above and beyond a relatively average execution, the main reason behind Unilever's below peers' operational performance in recent years resides in a portfolio skewed towards lower growth [and] lower gross margin categories," the bank's analysts said. They highlighted skin cleansing and fabric care as areas of particular concern given their price elasticity.For its part, management has done little to boost investor expectations. It maintained guidance of 3-5 per cent organic sales growth for 2024, with a "modest improvement" to operating margins. The forthcoming demerger of Unilever's ice cream business may also provide a modest boost to profitability once completed. UBS estimated the underperforming division shaved 90 basis points off the company's operating margin last year.Some brokers are hoping that other consumer goods groups embrace the logic of spin-offs. "We don't see what synergies there are from selling baby food and surface cleaner within the same business," Bernstein's analysts said following Reckitt's Q1 update. "At the current valuation we think that management should be looking more seriously at a radical change in their corporate strategy."Like Unilever, Reckitt delivered consensus-beating sales growth across the three months to the end of March. This was driven by gains in its hygiene division, which helped to offset continued declines in its troubled nutrition business. Haleon (HLN) is something of an outlier in the consumer goods cohort in that it's purely a healthcare group. Consumers tend not to trade down for cheaper medicines when inflation bites giving the company a defensive edge over peers with, say, food production divisions.In its first-quarter update, Haleon's management continued to guide for organic revenue growth of 4-6 per cent this year, putting it ahead of most of its peers. However, its top-line figures in the first quarter were down 2.2 per cent to £2.92bn, slightly lower than broker consensus of £2.93bn, due to a strong prior-year comparative and currency headwinds. Operating profit was ahead of expectations, growing by 4.5 per cent to £455mn on the back of higher gross margin and cost efficiencies.Its shares fell by 3 per cent, although this may have more to do with fears around a forthcoming share sale by Pfizer (US:PFE) than any qualms over performance. Haleon began its life as a joint venture between the US pharma giant and GSK (GSK) before being spun off by the latter in 2022. Pfizer still owns some 23 per cent of Haleon's stock, however, and intends to keep selling this down potentially constraining share price growth as it does.Ultimately, there are reasons to be cautious around the UK's blue-chip consumer groups, even if their top lines or growth prospects look healthy. A rebound in demand in some segments won't solve issues with corporate structures in the long run. While Haleon is still dealing with the consequences of its own demerger, its peers have to figure out if (and how) to structure spin-offs in their ranks. |
Posted at 15/4/2024 10:48 by essentialinvestor Slowdown in HUL weighing on the ULVR share price |
Posted at 28/11/2023 14:18 by essentialinvestor ULVR share price is nowhere near strong enough ad there would need to be an equity element with new shares issued.Since the last reported interest the cost of detveting debt has soared, so it's a complete non starter - at least at this point. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
